The roles of lymphoid cells such as CD4+ TILs and CD8+ TILs have been well elucidated in anti-tumor responses, while the complex role of myeloid cells such as CD14+ monocytes and CD15+ granulocytes have been relatively underexplored. This evidence concerns the gene CD4 and neoplasm.